FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3100643583> ?p ?o ?g. }

• W3100643583 abstract "Abstract Background Chronic urticaria (CU) is defined as recurrent urticaria lasting for more than 6 weeks. Objectives We aimed to characterize the phenotypes of patients with CU refractory to standard dose anti-H1 antihistamine treatment and search for clinical predictors of poor disease control. Methods Retrospective collection of data regarding clinical characteristics, comorbidities, treatment, and disease control of all adult refractory CU patients presenting to the Allergy and Immunology Department during 1 year. Results Sixty-one adult patients were included, 74% females, average age 44.5 years (18 to 84 years old). Most patients (78.7%) had initiated CU less than 1 year before enrolment. Chronic spontaneous urticaria (CSU) accounted for 55.7% of the patients, CSU associated with chronic inducible urticaria (CIndU) as a comorbidity for 44.3%, and angioedema was present in 55.7%. Medically-confirmed psychiatric disorders were present in 78.7%. Complementary diagnostic tests were performed in cases with more severe presentation (UAS7 ≥ 28 and/or UCT < 12) or with longer evolution (> 1 year), corresponding to 42 tested patient. Evidence for autoimmunity (positive anti-thyroid peroxidase antibodies, anti-nuclear antibodies or autologous serum test) was found in 45.2% (n = 19/42), and high C-reactive protein was present in 14.3% (n = 6/42), half of these also had positive antinuclear antibodies. Forty-six patients (75.4%) had at least one significant exacerbation, requiring medical appointment, emergency room, hospitalization or job absenteeism. The number of exacerbations correlated with the presence of angioedema (p = 0.022), with a recent diagnosis (< 1 year), and with higher UAS7 severity (p = 0.006). Although ClndU was associated with poor symptom control (p = 0.022), it was also associated with less exacerbations requiring medical observation or hospitalization (p = 0.015). All patients were using antihistamines and 21.3% (n = 13) of them were also under treatment with omalizumab, ciclosporine or montelukast for disease control. Conclusions Autoimmunity can affect about half of the patients with severe or long-term CU. UAS7 and angioedema are associated with disease exacerbations. UAS7 and UCT presented unequal accuracy, with UAS7 better associating with the occurrence of exacerbations and treatment doses. Patients with refractory CU frequently present psychiatric disorders. Accurate diagnostic tests, namely autoimmune parameters and inflammatory markers, should be recommended in some individual cases." @default.
• W3100643583 created "2020-11-23" @default.
• W3100643583 creator A5000246632 @default.
• W3100643583 creator A5003002623 @default.
• W3100643583 creator A5005106112 @default.
• W3100643583 creator A5037397201 @default.
• W3100643583 creator A5043225646 @default.
• W3100643583 creator A5044737783 @default.
• W3100643583 creator A5081525455 @default.
• W3100643583 date "2020-11-11" @default.
• W3100643583 modified "2023-10-15" @default.
• W3100643583 title "Refractory chronic urticaria in adults: clinical characterization and predictors of severity" @default.
• W3100643583 cites W12500048 @default.
• W3100643583 cites W1773647412 @default.
• W3100643583 cites W1975662198 @default.
• W3100643583 cites W1977177083 @default.
• W3100643583 cites W1978057436 @default.
• W3100643583 cites W1981404520 @default.
• W3100643583 cites W1993225559 @default.
• W3100643583 cites W2008892887 @default.
• W3100643583 cites W2018500139 @default.
• W3100643583 cites W2027664945 @default.
• W3100643583 cites W2030519779 @default.
• W3100643583 cites W2037982270 @default.
• W3100643583 cites W2044406722 @default.
• W3100643583 cites W2044944098 @default.
• W3100643583 cites W2107002864 @default.
• W3100643583 cites W2109951782 @default.
• W3100643583 cites W2122930216 @default.
• W3100643583 cites W2124081749 @default.
• W3100643583 cites W2131291377 @default.
• W3100643583 cites W2160151030 @default.
• W3100643583 cites W2172166516 @default.
• W3100643583 cites W2180180041 @default.
• W3100643583 cites W2198783875 @default.
• W3100643583 cites W2259918059 @default.
• W3100643583 cites W2313595264 @default.
• W3100643583 cites W2328174922 @default.
• W3100643583 cites W2336873088 @default.
• W3100643583 cites W2341125252 @default.
• W3100643583 cites W2411033312 @default.
• W3100643583 cites W2516548446 @default.
• W3100643583 cites W2552700865 @default.
• W3100643583 cites W2558299901 @default.
• W3100643583 cites W2593287671 @default.
• W3100643583 cites W2604176897 @default.
• W3100643583 cites W2761928046 @default.
• W3100643583 cites W2762706039 @default.
• W3100643583 cites W2768085516 @default.
• W3100643583 cites W2792948845 @default.
• W3100643583 cites W2793969733 @default.
• W3100643583 cites W2804965132 @default.
• W3100643583 cites W2899923123 @default.
• W3100643583 cites W2919075904 @default.
• W3100643583 cites W2934481534 @default.
• W3100643583 cites W2945453994 @default.
• W3100643583 cites W2950133034 @default.
• W3100643583 cites W2951855251 @default.
• W3100643583 cites W2959650581 @default.
• W3100643583 cites W3002698932 @default.
• W3100643583 cites W3011894307 @default.
• W3100643583 cites W4230208791 @default.
• W3100643583 cites W4251649120 @default.
• W3100643583 cites W2038092579 @default.
• W3100643583 doi "https://doi.org/10.1186/s13223-020-00496-0" @default.
• W3100643583 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7661155" @default.
• W3100643583 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33292453" @default.
• W3100643583 hasPublicationYear "2020" @default.
• W3100643583 type Work @default.
• W3100643583 sameAs 3100643583 @default.
• W3100643583 citedByCount "7" @default.
• W3100643583 countsByYear W31006435832022 @default.
• W3100643583 countsByYear W31006435832023 @default.
• W3100643583 crossrefType "journal-article" @default.
• W3100643583 hasAuthorship W3100643583A5000246632 @default.
• W3100643583 hasAuthorship W3100643583A5003002623 @default.
• W3100643583 hasAuthorship W3100643583A5005106112 @default.
• W3100643583 hasAuthorship W3100643583A5037397201 @default.
• W3100643583 hasAuthorship W3100643583A5043225646 @default.
• W3100643583 hasAuthorship W3100643583A5044737783 @default.
• W3100643583 hasAuthorship W3100643583A5081525455 @default.
• W3100643583 hasBestOaLocation W31006435831 @default.
• W3100643583 hasConcept C121332964 @default.
• W3100643583 hasConcept C126322002 @default.
• W3100643583 hasConcept C142424586 @default.
• W3100643583 hasConcept C149443304 @default.
• W3100643583 hasConcept C159654299 @default.
• W3100643583 hasConcept C163764329 @default.
• W3100643583 hasConcept C187212893 @default.
• W3100643583 hasConcept C203014093 @default.
• W3100643583 hasConcept C2777014857 @default.
• W3100643583 hasConcept C2777995640 @default.
• W3100643583 hasConcept C2778696486 @default.
• W3100643583 hasConcept C2779134260 @default.
• W3100643583 hasConcept C71924100 @default.
• W3100643583 hasConcept C87355193 @default.
• W3100643583 hasConcept C90924648 @default.
• W3100643583 hasConceptScore W3100643583C121332964 @default.
• W3100643583 hasConceptScore W3100643583C126322002 @default.
• W3100643583 hasConceptScore W3100643583C142424586 @default.

• next